Core biopsy diagnosis of ductal carcinoma in situ: An indication for sentinel lymph node biopsy

Current Surgery

Volumn 62, Issue 2, 2005, Pages 253-257

  Mittendorf, Elizabeth A ^a   Arciero, Cletus A ^a   Gutchell, Veronica ^a   Hooke, Jeff ^a   Shriver, Craig D ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Core biopsy; Ductal carcinoma in situ; Sentinel lymph node biopsy

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER SURGERY; CARCINOMA IN SITU; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; METASTASIS; MINIMALLY INVASIVE SURGERY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SURGICAL APPROACH; SURGICAL TECHNIQUE;

EID: 15844385435     PISSN: 01497944     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cursur.2004.09.011     Document Type: Article

References (28)

1. B.O. Anderson Axillary metastases with DCIS: Is the glass half empty or half full Ann Surg Oncol. 7 2000 631-633
2. C.E. Cox K. Nguyen R.J. Gray et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): Why map DCIS? Am Surg. 67 2001 513-521
3. M.J. Silverstein E.D. Gierson J.R. Waisman G.M. Senofsky W.J. Colburn P. Gamagami Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer. 73 1994 664-667
4. C. Yiangou S. Shousha H.D. Sinnett Primary tumour characteristics and axillary lymph node status in breast cancer Br J Cancer. 80 1999 1974-1978
5. R.J. Cote H.F. Peterson B. Chaiwun et al. International breast cancer study group Role of immunohistochemical detection of lymph-node metastases in management of breast cancer Lancet. 354 1999 896-900
6. K. Dowlatshahi M. Fan K.J. Bloom D.J. Spitz S. Patel H.C. Snider Jr Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study Cancer. 86 1999 990-996
7. P.J. Hainsworth J.J. Tjandra R.G. Stillwell et al. Detection and significance of occult metastases in node-negative breast cancer Br J Surg. 80 1993 459-463
8. M.A. McGuckin M.C. Cummings M.D. Walsh B.G. Hohn I.C. Bennett R.G. Wright Occult axillary node metastases in breast cancer: Their detection and prognostic significance Br J Cancer. 73 1996 88-95
9. I.A. Nasser A.K. Lee S. Bosari R. Saganich G. Heatley M.L. Silverman Occult axillary lymph node metastases in "node-negative" breast carcinoma Hum Pathol. 24 1993 950-957
10. M. Intra P. Veronesi G. Mazzarol et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast Arch Surg. 138 2003 309-313
11. T.A. Kelly J.A. Kim R. Patrick S. Grundfest J.P. Crowe Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ Am J Surg. 186 2003 368-370
12. N. Klauber-DeMore L.K. Tan L. Liberman et al. Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion Ann Surg Oncol. 7 2000 342-363
13. S. Pendas E. Dauway R. Giulian N.N. Ku C.E. Cox D.S. Reintgen Sentinel node biopsy in ductal carcinoma in situ patients Ann Surg Oncol. 7 2000 15-20
14. D. Krag D. Weaver T. Ashikago et al. The sentinel node in breast cancer: a multicenter validation study N Engl J Med. 339 1998 941-946
15. R.J. Jackman K.W. Nowels M.J. Shepard S.I. Finkelstein F.A. Marzoni Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia Radiology. 193 1994 91-95
16. L. Liberman D.D. Dershaw P.P. Rosen et al. Stereotaxic core biopsy of breast carcinoma: Accuracy at predicting invasion Radiology. 194 1995 379-381
17. M.B. Acheson R.G. Patton R.L. Howisey R.F. Lane A. Morgan Histologic correlation of image-guided core biopsy with excisional biopsy of nonpalpable breast lesions Arch Surg. 132 1997 815-821
18. F. Burbank Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: Improved accuracy with directional, vacuum-assisted biopsy Radiology. 202 1997 843-847
19. R.J. Jackman K.W. Nowels J. Rodriguez-Soto F.A. Marzoni S.I. Finkelstein M.J. Shepard Stereotactic automated large-core needle biopsy of nonpalpable breast lesions: False-negative and histologic underestimation rates after long-term follow-up Radiology. 210 1999 799-805
20. B. Won H.E. Reynolds C.L. Lazaridis V.P. Jackson Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum assisted device: Persistent underestimation of disease AJR. 173 1999 227-229
21. W.E. Burak K.E. Owens M.B. Tighe et al. Vacuum-assisted stereotactic breast biopsy Arch Surg. 135 2000 700-703
22. M.L. Darling D.N. Smith S.C. Lester Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision AJR. 175 2000 1341-1346
23. C.H. Lee D. Carter L.E. Philpotts et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: Can invasion be predicted? Radiology. 217 2000 466-470
24. R.F. Brem J.M. Schoonjans L. Sanow O.M.B. Gatewood Reliability of histologic diagnosis of breast cancer with stereotactic vacuum-assisted biopsy Am Surg. 67 2001 388-392
25. S. Pandelidis D. Heilman D. Jones K. Stough J. Trapeni Y. Suliman Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions Ann Surg Oncol. 10 2003 43-47
26. J.P. Crowe R.J. Patrick L.A. Rybicki et al. Does ultrasound core breast biopsy predict histologic finding on excisional biopsy? Am J Surg. 186 2003 397-399
27. A.E. Giuliano P.S. Dale R.R. Turner D.L. Morton S.W. Evans D.L. Krasne Improved axillary staging of breast cancer with sentinel lymphadenectomy Ann Surg. 222 1995 394-399
28. K.M. McMasters C. Chao S.L. Wong R.C. Martin 3rd M.J. Edwards Sentinel lymph node biopsy in patients with ductal carcinoma in situ: A proposal Cancer. 95 2000 15-20